ERCC excision repair 6 like 2" most likely refers to a protein that is similar to ERCC6, a member of the excision repair cross-complementing (ERCC) group of proteins, which are involved in the nucleotide excision repair (NER) pathway. NER is a vital DNA damage repair mechanism that removes a wide range of DNA lesions, including those induced by ultraviolet (UV) radiation, environmental mutagens, and certain agents.The ERCC6 protein, also known as Cockayne syndrome group B protein (CSB), is specifically implicated in transcription-coupled nucleotide excision repair (TC-NER), a sub-pathway of NER that rapidly removes DNA damage from the transcribed strand of active genes. This ensures the fidelity of transcription and blocks the potentially deleterious effects of DNA damage on gene expression.
A protein described as "ERCC excision repair 6 like 2" would suggest a protein that shares similarity with ERCC6 in terms of sequence, structure, or function. Such a protein might be part of the same DNA repair pathway, possibly acting to recognize DNA damage, recruit other repair factors, or modify the chromatin structure to allow access to the damaged DNA.The "like 2" designation could imply that it is a paralog of ERCC6, meaning it's a related gene that has evolved in the same organism due to a duplication event. Paralogs often have similar functions but can also evolve new roles or have specialized functions in different tissues or under different conditions.Since ERCC6 and its related proteins are essential for maintaining genomic stability, defects in these proteins can lead to disorders such as Cockayne syndrome, characterized by growth defects, premature aging, and photosensitivity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA synthesis, potentially impacting the expression of ERCC6L2. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, potentially affecting chromatin remodeling and ERCC6L2 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may influence gene expression and could potentially affect the expression of ERCC6L2. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, potentially impacting DNA synthesis and influencing ERCC6L2 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil inhibits thymidylate synthase, potentially affecting DNA repair and the expression of ERCC6L2. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates DNA, potentially impacting DNA repair and influencing ERCC6L2 expression. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib inhibits multiple kinases, potentially impacting signaling pathways associated with ERCC6L2 expression. | ||||||